BioAge Labs, Inc. (BIOA)

BioAge Labs Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Selling, General & Admin	-	14.51	9.45
Research & Development	-	33.89	30.52
Operating Expenses	-	48.4	39.97
Operating Income	-51.57	-48.4	-39.97
Interest Expense / Income	2.25	5.36	-0.22
Other Expense / Income	8.34	10.09	-0.02
Pretax Income	-62.16	-63.85	-39.72
Net Income	-62.16	-63.85	-39.72
Free Cash Flow	-47.85	-37.53	-36.28
EBITDA	-59.74	-58.33	-39.82
Depreciation & Amortization	0.17	0.16	0.13
EBIT	-59.91	-58.49	-39.95

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).